HPV Cancers
Showing 1 - 25 of 5,839
Cervical Cancer, HPV Cancers, Anal Cancer Trial run by the NCI (PDS0101, M7824, NHS-IL12)
Active, not recruiting
- Cervical Cancer
- +4 more
- PDS0101
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 24, 2023
Profiles of Expression in HPV+ Versus HPV Head and Neck Cancers
Not yet recruiting
- Head and Neck Cancer
- PCR - Immunohistochemistry - Immunolabelling
- (no location specified)
Nov 13, 2023
Cervical Cancer, Throat Cancer, Oropharynx Cancer Trial in New Brunswick (E7 TCR-T cells)
Not yet recruiting
- Cervical Cancer
- +20 more
- E7 TCR-T cells
-
New Brunswick, New Jersey
- +1 more
Jan 18, 2023
Oropharynx Squamous Cell Carcinoma Trial (HPV16 Ct-DNA dosing)
Not yet recruiting
- Oropharynx Squamous Cell Carcinoma
- HPV16 Ct-DNA dosing
- (no location specified)
Oct 13, 2022
HPV Trial in Dar es Salaam (Training on self-screening and HPV vaccination administration)
Not yet recruiting
- HPV
- Training on self-screening and HPV vaccination administration
-
Dar es Salaam, TanzaniaDar es Salaam
Nov 8, 2022
Cervical Dysplasia, Cervical Cancer Trial in New York (NavDx(R))
Recruiting
- Cervical Dysplasia
- Cervical Cancer
- NavDx(R)
-
New York, New YorkLenox Hill Hospital
Oct 31, 2022
Oropharyngeal Cancer Trial in Tampa (Radiotherapy fractionation)
Active, not recruiting
- Oropharyngeal Cancer
- Radiotherapy fractionation
-
Tampa, FloridaH Lee Moffitt Cancer Center and Research Institute
Feb 2, 2023
HPV-Associated Cervical Carcinoma, HPV-Related Carcinoma, HPV-Related Malignancy Trial in New Brunswick (Conditioning, E7 TCR-T
Not yet recruiting
- HPV-Associated Cervical Carcinoma
- +16 more
- Conditioning, E7 TCR-T cells, and aldesleukin
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Jan 17, 2023
Oropharyngeal Cancer, Human Papilloma Virus, Head Neck Cancer Trial (Fludarabine, Cyclophosphamide, NEXI-003 T cells)
Not yet recruiting
- Oropharyngeal Cancer
- +10 more
- Fludarabine
- +2 more
- (no location specified)
Dec 14, 2022
HPV Associated Cancers Trial in New York, Houston (TGN-S11, Pembrolizumab)
Not yet recruiting
- HPV Associated Cancers
-
New York, New York
- +1 more
Apr 25, 2023
Human Papillomavirus Viruses, Papillomavirus Vaccines Trial in Cincinnati (K-Talk Intervention (Storytelling and K-Bot),
Recruiting
- Human Papillomavirus Viruses
- Papillomavirus Vaccines
- K-Talk Intervention (Storytelling and K-Bot)
- +3 more
-
Cincinnati, OhioMinjin Kim
May 31, 2023
Human Papillomavirus-Related Carcinoma Trial in Austria, United States (procedure, biological, other)
Not yet recruiting
- Human Papillomavirus-Related Carcinoma
- Biospecimen Collection
- +4 more
-
Birmingham, Alabama
- +4 more
Aug 9, 2023
Recurrent Human Papillomavirus Type 16 Associated Cancer Trial in Birmingham, Baltimore (HPV 16 TA-CIN)
Withdrawn
- Recurrent Human Papillomavirus Type 16 Associated Cancer
- HPV 16 TA-CIN
-
Birmingham, Alabama
- +1 more
Nov 29, 2022
Screening Women With Prior HPV for Anal Neoplasia
Recruiting
- HPV-related Lower Genital Tract Neoplasias
- +2 more
- Diagnostic tests for anal cancer screening
-
New York, New York
- +3 more
Oct 19, 2022
Detecting HPV DNA in Anal and Cervical Cancers
Recruiting
- Cervical Cancer
- +5 more
- Radiation Treatment With or Without Chemotherapy
- +5 more
-
Chicago, Illinois
- +1 more
Mar 22, 2022
HPV 16+ Recurrent or Metastatic Cancer Trial (CD8 reduced peripheral blood cells taken from related donors vaccinated against
Not yet recruiting
- HPV 16+ Recurrent or Metastatic Cancer
- CD8 reduced peripheral blood cells taken from related donors vaccinated against HPV16
- Non-myeloablative allogeneic bone marrow transplant from related donors vaccinated against HPV16
- (no location specified)
Jun 27, 2022
Cervical Cancer, Anal Cancer, Head Neck Cancers Trial in Zhengzhou (Fludarabine + Cyclophosphamide, Interleukin-2, CRTE7A2-01
Recruiting
- Cervical Cancer
- +2 more
- Fludarabine + Cyclophosphamide
- +2 more
-
Zhengzhou, Henan, ChinaThe First Affiliated Hospital of Zhengzhou University
Jun 22, 2022
Human Papillomavirus-Related Carcinoma, Human Papillomavirus Positive Oropharyngeal Carcinoma, Human Papillomavirus Positive
Active, not recruiting
- Human Papillomavirus-Related Carcinoma
- +5 more
- HPV Specific T Cells
- +3 more
-
Houston, TexasHouston Methodist Hospital
Jan 10, 2022
Will Permit Sites to Proactively Assess TAA, HLA and HPV-16
Terminated
- Head and Neck Cancer
- +7 more
- Tumor Profiling
-
Scottsdale, Arizona
- +2 more
Dec 2, 2022
Head Neck Cancer, Cervical Cancer, Non-small Cell Carcinoma Trial in Scottsdale, Chapel Hill (TSC-204-A0201, TSC-204-C0702,
Not yet recruiting
- Head and Neck Cancer
- +20 more
- TSC-204-A0201
- +4 more
-
Scottsdale, Arizona
- +1 more
Aug 3, 2023
HPV Infection, Vaginal Cancer, Cervical Dysplasia Trial in Orléans (Vaginal Biopsy)
Recruiting
- HPV Infection
- +3 more
- Vaginal Biopsy
-
Orléans, FranceCHR Orléans
Apr 5, 2022
Human Papilloma Virus, HPV, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Chicago (HB-201, HB-202, Carboplatin)
Recruiting
- Human Papilloma Virus
- +3 more
- HB-201
- +4 more
-
Chicago, IllinoisUniversity of Chicago
Aug 11, 2022
Molecular Signatures of HPV+ ORL Cancers (OROPAP)
Completed
- Oropharyngeal Cancer
- Human Papillomavirus-Related Carcinoma
-
Paris, Ile-de-France, FranceHôpital Européen Georges Pompidou
Oct 1, 2021
Vaccine Refusal Trial in Shanghai (Broadened information about cancers, Information about STDs, Information about infectious
Active, not recruiting
- Vaccine Refusal
- Broadened information about cancers
- +7 more
-
Shanghai, ChinaShanghai CDC
Jan 29, 2022
HPV-Associated Cancers Trial in Canada, United States (Ad-E6E7, MG1-E6E7, Atezolizumab)
Active, not recruiting
- HPV-Associated Cancers
- Ad-E6E7
- +2 more
-
Miami, Florida
- +7 more
Sep 30, 2021